Listen to ValSource Viewpoints Annex 1 Podcast
ValSource Viewpoints is back with a new Annex 1 podcast series. Tune in often as we release regular episodes concerning the revision to Annex 1 — the European Medicine Agency’s requirements for producing sterile medicinal products. Subscribe and listen to ValSource Viewpoints on Spotify, Apple Podcasts, & Google Play.
Our Latest Topic:
We are thought leaders and innovators, helping to drive industry standards. We are experts in navigating regulated industries and the rigorous requirements that accompany them.
Intelligent approaches, speed to market and solutions which our clients can sustain. We provide results for the most effective outcomes.
Reach a qualified and validated state, with ValSource as your guide.
From technical assessments to complete project planning, we provide strategic and hands-on operational support.
From clinical trials to manufacturing and distribution, ValSource is your partner in compliance.
Commissioning, Qualification & Validation
Planned and performed correctly in an integrated manner to ensure operational eﬃciency.
The ValSource safety team can swiftly plan, direct, and implement a proper safety program to ensure a safe, healthy, and accident-free project and work environment.
Conducted as a sustained and consistent activity provides valuable information at every stage of the process lifecycle.
Quality Risk Management
Just how much will risk-based thinking impact your efficiency and outcomes? Let us find out.
Microneedle & Transdermal Delivery
From pre-IND stages through commercialization, we have the expertise to help navigate the complex regulatory environment for microbiological control of microneedles and other novel transdermal products.
Metrology & Calibration
We solve overlaps in instrument validation and calibration processes – providing both services in one.
Our proven approach to ensure quality and eliminate risk. We are committed to help our clients get to a qualified and validated state by applying the most efficient solutions.